La nuova revisione Cochrane sui farmaci anti-amiloidi per l'Alzheimer, guidata dal direttore di Cochrane Italia Francesco Nonino, epidemiologo e neurologo dell'IRCSS Istituto delle Scienze Neurologiche di Bologna, e Edo Richards, professore di Neurologia presso la Radboud University Medical Centre in Nijmegen, Paesi Bassi, e Chair dello Scientific Advisory Group on Neurology per la European Medical Agency (EMA), è stata ripresa dalle principali testate giornalistiche a livello mondiale.
Ecco un elenco (in continuo aggiornamento) dei principali articoli.
- Cochrane News alert & Press Release
- Bakchine S, Colosimo C, Emilsson E, Jónsdóttir S E, Massacesi L, Nonino F et al. Concerns about the approval of lecanemab for Alzheimer’s disease BMJ 2025; 389 :r778 doi:10.1136/bmj.r778
- Wise J. Alzheimer’s drugs targeting amyloid do not produce clinically meaningful effects, concludes Cochrane review BMJ 2026; 393 :s719 doi:10.1136/bmj.s719
Italiano
Quotidiano Sanità
Il Manifesto
https://ilmanifesto.it/italia-controcorrente-sui-farmaci-anti-alzheimer
AboutPharma
NeuroInfo
Repubblica
FanPage.it
Sanità33
Scienze Notizie
English
Science
Anti-Amyloid Antibodies for Alzheimer: You Already Know by Derek Lowe
BBC News
https://www.bbc.co.uk/news/articles/cql77wlqlx7o
Guardian
https://www.theguardian.com/society/2026/apr/16/effect-gamechanger-alzheimers-drugs-trivial-review-concludes
Times
https://www.thetimes.com/uk/healthcare/article/alzheimers-dementia-nhs-cochrane-review-57l2dkqs6
https://archive.is/20260417160716/https:/www.thetimes.com/comment/columnists/article/wrong-about-treatment-alzheimers-ppbd8z5c9
Bloomberg
https://www.bloomberg.com/news/articles/2026-04-16/alzheimer-s-drugs-targeting-amyloid-don-t-help-review-finds?embedded-checkout=true
Independent (via PA)
https://www.independent.co.uk/news/health/alzheimers-drugs-review-lecanemab-donanemab-b2958258.html
Evening Standard (via PA)
https://www.standard.co.uk/news/health/alzheimer-national-institute-for-health-and-care-excellence-netherlands-nhs-cochrane-b1278889.html
New York Times
https://www.independent.co.uk/news/health/alzheimers-drugs-review-lecanemab-donanemab-b2958258.html
RTE
https://www.rte.ie/news/health/2026/0416/1568493-alzheimers-drug/
Daily Mail
https://www.dailymail.co.uk/health/article-15737945/Dementia-drugs-Alzheimers-dementia-not-work.html
Sun
https://www.thesun.co.uk/health/38832005/alzheimer-drugs-fail-dementia-treatment/
Mirror
https://www.mirror.co.uk/news/health/alzheimers-bombshell-top-scientists-conclude-37022491
LBC News
https://www.lbc.co.uk/article/alzheimers-wonder-drugs-dont-work-5HjdXmw_2/
Daily Express
https://www.express.co.uk/life-style/health/2194634/alzheimer-s-bombshell-meds-make-difference-cause-bleeding
https://www.express.co.uk/news/uk/2194524/dementia-drugs-bombshell-cochrane-review
Telegraph
https://www.telegraph.co.uk/health-fitness/conditions/dementia/neurologist-miracle-dementia-drugs-dont-work/
https://www.telegraph.co.uk/news/2026/04/16/alzheimers-wonder-drugs-do-not-work/
https://uk.style.yahoo.com/went-wrong-race-cure-dementia-100000634.html
Market Watch (with comment from Cochrane Deputy Editor in Chief Toby Lasserson)
Español
El Mundo
La Razón
Duro revés para los nuevos fármacos contra el alzhéimer: una revisión científica advierte riesgos
Science Media Centre España
SINC
Los fármacos antiamiloides para el alzhéimer no muestran beneficios clínicamente significativos
Edición Médica
Revisión científica cuestiona medicamentos antiamiloides para el alzhéimer
El Debate
Los fármacos antiamiloide para el alzhéimer no muestran un efecto clínico significativo
Infobae
Un estudio evaluó los fármacos para el Alzheimer en 20 mil personas: cuáles fueron sus hallazgos
Svenska
Dagens Nyheter
https://www.dn.se/sverige/nya-lakemedel-mot-alzheimers-sagas-i-ny-rapport/
Non trovi il tuo articolo? Segnalalo a cochrane.italia@ausl.bologna.it
Can’t find your article? Let us know at cochrane.italia@ausl.bologna.it